Janneth González

Dr. Janneth González

orcid

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
31 January 2020 in Frontiers in Neuroscience
Verified
Journal Article
Open access
PDF file
DODaniel Osorio
Daniel Osorio
APAndres Pinzon
Andres Pinzon
CMCynthia Martín-Jiménez
Cynthia Martín-Jiménez
GBGeorge E. Barreto
George E. Barreto
JGJanneth González
Janneth González
Inflammation is a complex biological response to injuries, metabolic disorders or infections. In the brain, astrocytes play an important role in the inflammatory processes during neurodegenerative diseases. Recent studies have shown that the increase of free saturated fatty acids such as palmitic acid produces a metabolic inflammatory response in astrocytes generally associated with damaging mechanisms such as oxidative stress, endoplasmic reticulum stress, and autophagic defects. In this aspect, the synthetic neurosteroid tibolone has shown to exert protective functions against inflammation in neuronal experimental models without the tumorigenic effects exerted by sexual hormones such as estradiol and progesterone. However, there is little information regarding the specific mechanisms of tibolone in astrocytes during inflammatory insults. In the present study, we performed a genome-scale metabolic reconstruction of astrocytes that was used to study astrocytic response during an inflammatory insult by palmitate through Flux Balance Analysis methods and data mining. In this aspect, we assessed the metabolic fluxes of human astrocytes under three different scenarios: healthy (normal conditions), induced inflammation by palmitate, and tibolone treatment under palmitate inflammation. Our results suggest that tibolone reduces the L-glutamate-mediated neurotoxicity in astrocytes through the modulation of several metabolic pathways involved in glutamate uptake. We also identified a set of reactions associated with the protective effects of tibolone, including the upregulation of taurine metabolism, gluconeogenesis, cPPAR and the modulation of calcium signaling pathways. In conclusion, the different scenarios studied in our model allowed us to identify several metabolic fluxes perturbed under an inflammatory response and the protective mechanisms exerted by tibolone.

16 September 2022 in Life
Verified
Journal Article
Open access
PDF file
AGAngelica Estefania Ramirez Gracia
Angelica Estefania Ramirez Gracia
NGNatalia Gil-Jaramillo
Natalia Gil-Jaramillo
MTMaría Alejandra Tapias
María Alejandra Tapias
YGYeimy González-Giraldo
Yeimy González-Giraldo
APAndres Pinzon
Andres Pinzon
JGJanneth González
Janneth González
The importance of miRNAs in cellular processes and their dysregulation has taken significant importance in understanding different pathologies. Due to the constant increase in the prevalence of neurodegenerative diseases (ND) worldwide and their economic impact, mild cognitive impairment (MCI), considered a prodromal phase, is a logical starting point to study this public health problem. Multiple studies have established the importance of miRNAs in MCI, including astrocyte regulation during stressful conditions. Additionally, the protection mechanisms exerted by astrocytes against some damage in the central nervous system (CNS) lead to astrocytic reactivation, in which a differential expression of miRNAs has been shown. Nevertheless, excessive reactivation can cause neurodegeneration, and a clear pattern defining the equilibrium point between a neuroprotective or detrimental astrocytic phenotype is unknown. Therefore, the miRNA expression has gained significant attention to understand the maintenance of brain balance and improve the diagnosis and treatment at earlier stages in the ND. Here, we provide a comprehensive review of the emerging role of miRNAs in cellular processes that contribute to the loss of cognitive function, including lipotoxicity, which can induce chronic inflammation, also considering the fundamental role of astrocytes in brain homeostasis.

13 February 2017 in Frontiers in Aging Neuroscience
Verified
Journal Article
Open access
CMCynthia A. Martín-Jiménez
Cynthia A. Martín-Jiménez
DSDiego Salazar-Barreto
Diego Salazar-Barreto
GBGeorge E. Barreto
George E. Barreto
JGJanneth González
Janneth González
Astrocytes are the most abundant cells of the central nervous system; they have a predominant role in maintaining brain metabolism. In this sense, abnormal metabolic states have been found in different neuropathological diseases. Determination of metabolic states of astrocytes is difficult to model using current experimental approaches given the high number of reactions and metabolites present. Thus, genome-scale metabolic networks derived from transcriptomic data can be used as a framework to elucidate how astrocytes modulate human brain metabolic states during normal conditions and in neurodegenerative diseases. We performed a Genome-Scale Reconstruction of the Human Astrocyte Metabolic Network with the purpose of elucidating a significant portion of the metabolic map of the astrocyte. This is the first global high-quality, manually curated metabolic reconstruction network of a human astrocyte. It includes 5,007 metabolites and 5,659 reactions distributed among 8 cell compartments, (extracellular, cytoplasm, mitochondria, endoplasmic reticle, Golgi apparatus, lysosome, peroxisome and nucleus). Using the reconstructed network, the metabolic capabilities of human astrocytes were calculated and compared both in normal and ischemic conditions. We identified reactions activated in these two states, which can be useful for understanding the astrocytic pathways that are affected during brain disease. Additionally, we also showed that the obtained flux distributions in the model, are in accordance with literature-based findings. Up to date, this is the most complete representation of the human astrocyte in terms of inclusion of genes, proteins, reactions and metabolic pathways, being a useful guide for in-silico analysis of several metabolic behaviors of the astrocyte during normal and pathologic states.

1 February 2016 in Molecular Genetics and Metabolism
Verified
Journal Article
Closed access
DSDiego A. Salazar
Diego A. Salazar
ARAlexander Rodriguez-Lopez
Alexander Rodriguez-Lopez
AHAngélica Herreño
Angélica Herreño
HBHector Barbosa
Hector Barbosa
JHJuliana Herrera
Juliana Herrera
Carlos Javier Alméciga-DíazCarlos Javier Alméciga-Díaz
Carlos Javier Alméciga-Díaz

9 September 2022 in Pharmaceutics
Verified
Journal Article
Open access
PDF file
LALily Arrue
Lily Arrue
ACAlexandra Cigna-Méndez
Alexandra Cigna-Méndez
TBTabata Barbosa
Tabata Barbosa
Paola Borrego-MuñozPaola Borrego-Muñoz
Paola Borrego-Muñoz
SSSilvia Struve-Villalobos
Silvia Struve-Villalobos
David RamirezDavid Ramirez
David Ramirez
Neurodegenerative diseases (NDD) have been of great interest to scientists for a long time due to their multifactorial character. Among these pathologies, Alzheimer’s disease (AD) is of special relevance, and despite the existence of approved drugs for its treatment, there is still no efficient pharmacological therapy to stop, slow, or repair neurodegeneration. Existing drugs have certain disadvantages, such as lack of efficacy and side effects. Therefore, there is a real need to discover new drugs that can deal with this problem. However, as AD is multifactorial in nature with so many physiological pathways involved, the most effective approach to modulate more than one of them in a relevant manner and without undesirable consequences is through polypharmacology. In this field, there has been significant progress in recent years in terms of pharmacoinformatics tools that allow the discovery of bioactive molecules with polypharmacological profiles without the need to spend a long time and excessive resources on complex experimental designs, making the drug design and development pipeline more efficient. In this review, we present from different perspectives how pharmacoinformatics tools can be useful when drug design programs are designed to tackle complex diseases such as AD, highlighting essential concepts, showing the relevance of artificial intelligence and new trends, as well as different databases and software with their main results, emphasizing the importance of coupling wet and dry approaches in drug design and development processes.

7 August 2020 in Frontiers in Neuroinformatics
Verified
Journal Article
Open access
PDF file
JGJanneth González
Janneth González
APAndrés Pinzón
Andrés Pinzón
AAAndrea Angarita-Rodríguez
Andrea Angarita-Rodríguez
Andres Felipe Aristizabal-PachonAndres Felipe Aristizabal-Pachon
Andres Felipe Aristizabal-Pachon
GBGeorge E. Barreto
George E. Barreto
CMCynthia Martín-Jiménez
Cynthia Martín-Jiménez
The growing importance of astrocytes in the field of neuroscience has led to a greater number of computational models devoted to the study of astrocytic functions and their metabolic interactions with neurons. The modeling of these interactions demands a combined understanding of brain physiology and the development of computational frameworks based on genomic-scale reconstructions, system biology, and dynamic models. These computational approaches have helped to highlight the neuroprotective mechanisms triggered by astrocytes and other glial cells, both under normal conditions and during neurodegenerative processes. In the present review, we evaluate some of the most relevant models of astrocyte metabolism, including genome-scale reconstructions and astrocyte-neuron interactions developed in the last few years. Additionally, we discuss novel strategies from the multi-omics perspective and computational models of other glial cell types that will increase our knowledge in brain metabolism and its association with neurodegenerative diseases.